Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.900 | 10 | 2001 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms | 0.100 | 0.800 | 10 | 2004 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.700 | 10 | 2009 | 2020 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.900 | 10 | 2001 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.900 | 10 | 2001 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms | 0.100 | 0.800 | 10 | 2004 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms | 0.090 | 0.889 | 9 | 2012 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.080 | 0.875 | 8 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.714 | 7 | 2003 | 2016 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.714 | 7 | 2003 | 2016 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.060 | 0.667 | 6 | 2002 | 2016 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 0.200 | 5 | 2012 | 2017 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2010 | 2013 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 0.750 | 4 | 2006 | 2016 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.040 | 0.500 | 4 | 2011 | 2018 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Neoplasms | 0.030 | 0.333 | 3 | 2013 | 2014 | |||||||
|
0.550 | 0.720 | 19 | 43552260 | missense variant | C/G;T | snv | 8.5E-06; 7.1E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2007 | 2016 |